You are here: Industry Insights > cancer

News List

Clinical trial to develop breath test for cancer launched europeanpharmaceuticalreview
January 04, 2019
A clinical trial to analyse breath for volatile organic compounds to detect different types of cancer has been launched by Cancer Research UK…
Propanc Biopharma Commences Drug Discovery Research Collaboration pharmafocusasia
January 04, 2019
Propanc Biopharma, Inc., a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic.....
Off-the-shelf cell therapy for cancer? Fate Therapeutics to make its case at ASH fiercebiotech
January 03, 2019
Shares of cell therapy developer Fate Therapeutics shot up more than 8% Friday morning to $15.31 after the company announced that the FDA accepted its IND application for a ......
Using water and gold, Australian researchers discover ‘universal cancer biomarker’ fiercebiotech
January 02, 2019
Australian researchers at the University of Queensland have discovered a unique DNA structure that appears to be shared by many cancers and could be used to .....
Lupin in partnership with AbbVie en-cphi.cn
December 26, 2018
To develop and commercialise a novel oncology drug to treat haematological cancers
Bristol-Myers, H3 Biomedicine explore RNA splicing drugs for cancer fiercebiotech
December 25, 2018
Bristol-Myers Squibb is tapping Eisai spinoff H3 Biomedicine and its RNA-splicing technology for a multiyear research partnership....
Erasca picks up $42M to target biological drivers of cancer fiercebiotech
December 25, 2018
Erasca has raised a $42 million series A round from the likes of City Hill Ventures and Cormorant Asset Management to work toward the lofty goal to “not just treat, but actually cure cancer.” ....
G1 tanks after placebo beats drug in cancer response rate test fiercebiotech
December 25, 2018
G1 Therapeutics’ cancer drug trilaciclib has failed to beat placebo against multiple efficacy measures in phase 2. Trilaciclib performed well against its neutropenia-related primary endpoints but....
Relay Therapeutics bags $400M to ramp up discovery and push into the clinic fiercebiotech
December 25, 2018
Two weeks after expanding its R&D team, Relay Therapeutics is reeling in a massive $400 million series C round to boost its platform technology and discovery efforts, build its pipeline and get into the clinic......
Merck KGaA, Intrexon Amend CAR-T Alliance contractpharma
December 21, 2018
Merck KGaA, Darmstadt, Germany, through its wholly owned subsidiary, Ares Trading, amended its agreement with Intrexon Corp.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 87 88 Next page